Competition & Peer Data API & CSV Delivery

Exousia Bio Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Exousia Bio Inc (LMMY) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q2 2025

API endpoints for this dataset

                        https://api.csimarket.com/api/v1/companies/LMMY/competitors                    

                        https://api.csimarket.com/api/v1/companies/LMMY/relationships                    

                        https://api.csimarket.com/api/v1/companies/LMMY/similar                    

Programmatic access for models, analytics, and integration workflows.

Pull these exact ratios programmatically

Get an API key License this feed for redistribution / AI →

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LMMY Stock Performance relative to its Competitors

LMMY Competitors (weighted) Percent change over the selected range

Exousia Bio Inc's Comment on Competition and Industry Peers

The company operates in a specialized market segment with multiple competitors. Its business model emphasizes the use of new technologies and innovations to reduce costs and achieve competitive advantages, especially in developing economies. The company has relatively low startup costs, ease of market entry, and proximity to clients compared to larger firms, which lowers barriers to entry. It does not require government approval for its main products or services and holds trademark protection for the twoplus1® brand in the United Kingdom, with plans to expand this protection to other key regions.

Competitor data is not yet available for Exousia Bio Inc.